BCAX
Bicara Therapeutics Inc. Common Stock
NASDAQ: BCAX · HEALTHCARE · BIOTECHNOLOGY
$21.58
+1.41% today
Updated 2026-04-30
Market cap
$1.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.52
Dividend yield
—
52W range
$8 – $24
Volume
0.6M
Bicara Therapeutics Inc. Common Stock (BCAX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $6.70M | $233.98M | $569.20M |
| Cash & equivalents | $4.16M | $230.44M | $489.71M |
| Current assets | $4.98M | $231.07M | $502.53M |
| Total liabilities | $23.98M | $15.47M | $77.32M |
| Current liabilities | $23.90M | $15.09M | $17.99M |
| Long-term debt | — | — | — |
| Shareholder equity | $-17.28M | $218.51M | $491.88M |
| Retained earnings | $-101.04M | $-153.02M | $-221.02M |
| Accounts receivable | — | — | — |
| Inventory | — | — | — |
| Goodwill | — | — | — |